| Symbol |
Name |
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ACKR2
|
atypical chemokine receptor 2
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADM
|
adrenomedullin
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
ALPI
|
alkaline phosphatase, intestinal
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA1
|
annexin A1
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BPIFA1
|
BPI fold containing family A, member 1
|
|
BPIFB1
|
BPI fold containing family B, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
C3
|
complement component 3
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CALB2
|
calbindin 2
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD1D
|
CD1d molecule
|
|
CD2
|
CD2 molecule
|
|
CD209
|
CD209 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD8A
|
CD8a molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLCA1
|
chloride channel accessory 1
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CORO1B
|
coronin, actin binding protein, 1B
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREM
|
cAMP responsive element modulator
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTTN
|
cortactin
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL17
|
chemokine (C-X-C motif) ligand 17
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPHA3
|
EPH receptor A3
|
|
F11R
|
F11 receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FERMT1
|
fermitin family member 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FLG
|
filaggrin
|
|
FOXP3
|
forkhead box P3
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GCNT3
|
glucosaminyl (N-acetyl) transferase 3, mucin type
|
|
GCRG224
|
gastric cancer-related gene GCRG224
|
|
GDF15
|
growth differentiation factor 15
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GKN1
|
gastrokine 1
|
|
GP2
|
glycoprotein 2 (zymogen granule membrane)
|
|
GPX2
|
glutathione peroxidase 2
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HDAC6
|
histone deacetylase 6
|
|
HDC
|
histidine decarboxylase
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGB1
|
high mobility group box 1
|
|
HPSE
|
heparanase
|
|
HRH2
|
histamine receptor H2
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF2
|
interferon regulatory factor 2
|
|
IRF9
|
interferon regulatory factor 9
|
|
IRGM
|
immunity-related GTPase family, M
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
LCN2
|
lipocalin 2
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LOX
|
lysyl oxidase
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LTF
|
lactotransferrin
|
|
LYZ
|
lysozyme
|
|
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR155
|
microRNA 155
|
|
MIR27A
|
microRNA 27a
|
|
MIR424
|
microRNA 424
|
|
MIR503
|
microRNA 503
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NPY2R
|
neuropeptide Y receptor Y2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTN1
|
netrin 1
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
OCLN
|
occludin
|
|
PAX8
|
paired box 8
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PGLYRP1
|
peptidoglycan recognition protein 1
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PYCARD
|
PYD and CARD domain containing
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SHH
|
sonic hedgehog
|
|
SLC29A2
|
solute carrier family 29 (equilibrative nucleoside transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TFF2
|
trefoil factor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGM2
|
transglutaminase 2
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TJP1
|
tight junction protein 1
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPAN7
|
tetraspanin 7
|
|
TST
|
thiosulfate sulfurtransferase (rhodanese)
|
|
UCN
|
urocortin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIP
|
vasoactive intestinal peptide
|
